chr19-48974658-G-A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The ENST00000323798.8(GYS1):c.1384C>T(p.Arg462Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000041 in 1,461,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000323798.8 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GYS1 | NM_002103.5 | c.1384C>T | p.Arg462Ter | stop_gained | 11/16 | ENST00000323798.8 | NP_002094.2 | |
GYS1 | NM_001161587.2 | c.1192C>T | p.Arg398Ter | stop_gained | 10/15 | NP_001155059.1 | ||
GYS1 | NR_027763.2 | n.1399C>T | non_coding_transcript_exon_variant | 10/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GYS1 | ENST00000323798.8 | c.1384C>T | p.Arg462Ter | stop_gained | 11/16 | 1 | NM_002103.5 | ENSP00000317904 | P1 | |
GYS1 | ENST00000263276.6 | c.1192C>T | p.Arg398Ter | stop_gained | 10/15 | 1 | ENSP00000263276 | |||
GYS1 | ENST00000472004.5 | n.139C>T | non_coding_transcript_exon_variant | 2/4 | 3 | |||||
GYS1 | ENST00000496048.1 | n.291C>T | non_coding_transcript_exon_variant | 3/5 | 3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251412Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135884
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461762Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727206
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Glycogen storage disease due to muscle and heart glycogen synthase deficiency Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 11, 2007 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 29, 2023 | This sequence change creates a premature translational stop signal (p.Arg462*) in the GYS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GYS1 are known to be pathogenic (PMID: 17928598, 19699667). This variant is present in population databases (rs121434584, gnomAD 0.002%). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 16057). This premature translational stop signal has been observed in individual(s) with glycogen storage disease (PMID: 17928598). It has also been observed to segregate with disease in related individuals. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at